wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

CVS Respi C4

Total questions: 15

Worksheet time: 8mins

Name
Class
Date
1.

Treatment Step 3 for moderate persistent asthma involves which of the following?

a)

 High-dose inhaled corticosteroid

b)

Medium-dose inhaled corticosteroid + montelukast

c)

Medium-dose inhaled corticosteroid + long acting beta agonist

d)

Medium-dose inhaled corticosteroid

e)

Low-dose inhaled corticosteroid

2.

Choose the incorrect statement.

a)

Chest findings during routine clinic visits are often normal in children with asthma.

b)

Diurnal variation of 15% in peak expiratory volume can be explained by asthma

c)

 FEV1/FVC ratio less than 0.80 is consistent with asthma

d)

FEV1 decreases during or after exercise by >15% in an asthmatic person

3.

Which of these is not found in patients with asthma?

a)

Curschmann spirals

b)

Charcot-Leyden crystals

c)

Anitschkow cells

d)

Anitschkow cells

4.

 Choose the correct statement regarding the pathogenesis of asthma.

a)

 The early-phase reaction is dominated by recruitment of leukocytes.

b)

The late-phase reaction is dominated by bronchoconstriction, increased mucus production, vasodilation, and increased vascular permeability.

c)

 Atopic asthma is a classic example of type IV hypersensitivity reaction.

d)

 Leukotrienes C4, D4, E4 cause prolonged bronchoconstriction, increased vascular permeability, and increased mucus secretion.

5.

Second most common cause of bronchiolitis

a)

   RSV

b)

Parainfluenza

c)

  Influenza

d)

Rhinovirus

6.

Virus responsible for bronchiolitis obliterans

a)

 Bocavirus

b)

Adenovirus

c)

 RSV

d)

Influenza

7.

 Prophylaxis given for bronchiolitis

a)

  Ribavarin

b)

Zanamivir

c)

 Peramivir

d)

Palivizumab

8.

Which of the following is not true based from the 2021 AAP recommendations for bronchiolitis?

a)

  Diagnosis should be made clinically

b)

  Hypertonic saline can be used in the ER

c)

Antibiotics is not recommended

d)

  Supplemental O2 for hypoxemia

9.

  The following are parameters for PICU admission in patients with bronchiolitis, except which:

a)

 Desaturation <95% despite 3L O2

b)

Altered mental status

c)

Apnea >20s with associated bradycardia

d)

    Requires suctioning more frequently

10.

Which of the following best describes the law of LaPlace?

a)

Alveolar pressure is inversely proportional with surface tension of alveoli.

b)

Alveolar pressure is directly proportional with radius of alveoli. 

c)

Alveolar pressure of large alveoli greater than small alveoli if both surface tension is equal.

d)

Alveolar pressure of large alveoli is lesser than small alveoli if both surface tension is equal.

11.

Which of the following anatomy of the lung extends downward from the spinous process of the 7th cervical vertebra up to the 10th thoracic vertebra: and it lies about 1.5 in. (4 cm) from the midline?

a)

Lower border of the lung

b)

Posterior border of the lung

c)

Oblique fissure of the lung

d)

Horizontal fissure of the lung

12.

Which of the following is the true primary cause if the ABG results are pH= 7.27, PaCO2= 53, HCO3= 24, and PaO2= 50?

a)

Metabolic acidosis

b)

Metabolic alkalosis

c)

Respiratory acidosis

d)

Respiratory alkalosis

13.

A discontinuous, low-frequency, and grating sound that arises from inflammation and roughening of the visceral pleura as it slides against the parietal pleura is known as.

a)

Mediastinal crunch

b)

Pleural rub

c)

Fine crackles

d)

Coarse crackles

14.

This type of breath sound is often heard in the 1st and 2nd interspaces anteriorly and between the scapulae.

a)

Vesicular

b)

Tracheal

c)

Bronchial

d)

Bronchovesicular

15.

 After successful treatment of the acute  attack, the patient was referred to the outpatient clinic for follow-up treatment for asthma. Which of the following is not an  established prophylactic strategy for asthma?

a)

Avoidance of antigen exposure

b)

 Blockade of histamine receptors

c)

Use of montelukast

d)

IL-5 cytokine blockade

e)

Inhibition of phospholipase A2